HR 4762
Medical Supply Sanctions Act of 2025
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This bill would prevent the United States from exporting drugs and prosthetics to Russia. The bill defines ‘drug’ and ‘prosthetic’ for clarity and establishes a sunset provision, meaning the ban will end when the Secretary of State confirms Russia has ceased military operations in Ukraine. The goal of this legislation is to restrict the flow of medical supplies to Russia, potentially impacting the Russian healthcare system.
Key provisions
- Prohibits the export of drugs to Russia.
- Prohibits the export of prosthetics to Russia.
- Defines ‘drug’ as a medication with FDA approval.
- Defines ‘prosthetic’ as a medical device replacing or improving body function and authorized by the FDA.
- Includes components of drugs and prosthetics in the export ban.
- Establishes a sunset provision for the ban.
Who is affected
- U.S. exporters of drugs
- U.S. exporters of prosthetics
- The Russian Federation
- The Russian healthcare system
Notable changes
- Creates a specific export ban on drugs and prosthetics to Russia.
- Adds a sunset provision tied to a certification from the Secretary of State regarding the situation in Ukraine.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.
119th CONGRESS — 1st Session
H. R. 4762
IN THE HOUSE OF REPRESENTATIVES
A BILL
To prohibit the export of drugs and prosthetics to the Russian Federation.
This Act may be cited as the Medical Supply Sanctions Act of 2025
.
In this section:
The term drug—
means a drug (as defined in section 201 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321)) for which an approval is in effect under section 505 of such Act (21 U.S.C. 355) or section 351 of the Public Health Service Act (42 U.S.C. 262); and
includes any component thereof.
means a medical device that—
replaces a missing body part or improves the function of an existing body part; and
is authorized for marketing by the Food and Drug Administration; and
includes any component, part, or accessory thereof.
This prohibition required by subsection (a) shall terminate on the date on which the Secretary of State certifies to Congress that the Russian Federation has ceased military operations in Ukraine and has removed its military forces from Ukraine.